Phillips Medisize

A close up image of a roll of blister packaging feeding through a machine to be prepared to be inserted into a dry powder inhaler

Bespoke Inhalation Device Design

The optimal choice of drug delivery platform technology is critical to the success of an inhaled development program. Making the right choices at each development stage can have a significant impact on the development timeline, cost and probability of success for the program.

Our expert inhalation device engineers offer tailored bespoke design services specifically around your formulation, patient and commercial requirements. These capabilities encompass all disciplines of engineering from human factors to mechanical to software and more.

Additionally, the Phillips Medisize team’s expertise across all phases of device design, development and scaled manufacturing offers a myriad of benefits to customers. Our device engineers collaborate with you across each step of the process:

Feasibility

Stage 1: Research and strategy

Stage 2: Concept and feasibility

Development

Stage 3: Proof of concepts and design inputs

Stage 4: Design specification and detailed design

Stage 5: Manufacturing process and product development

Stage 6: Design verification and validation

Manufacturing

Stage 7: New product introduction (NPI)

Stage 8: Commercialization

Explore how our device platform products can support your inhaled program:

An image of a scientist in a lab coat working on testing a Dry Powder Inhaler
Dry Powder Inhalers (DPI)
Capsule- and blister-based capabilities, including unit-dose, multidose and high payload devices
Learn more
A close-up image of a Metered Dose Inhaler against a navy blue background
Metered-dose Inhalers (pMDI)
Extensive expertise and a proven track record
Learn more
An image of a scientist working on the development of the FOX Vibrating Mesh Nebulizer
FOX™ Vibrating Mesh Nebulizer
Small, handheld, breath- activated, battery-powered inhalation system that delivers nebulized liquid drugs with high performance using a vibrating mesh technology
Learn more

FOX™ is a registered trademark of Vectura.

FOX™ Vibrating Mesh Nebulizer from Phillips Medisize
ODD: Integrating Phillips Medisize and Vectura’s Operations
In this interview, Phillips Medisize’s Charlie Schumacher and Sandy Munro discuss the company’s progress on its integration of Vectura. Learn more.
OnDrug Delivery July 2025 cover.
ODD: Phillips Medisize Grows its Capabilities with Vectura
In this exclusive interview with ONdrugDelivery’s Guy Furness, Brian Thompson and Dave Thoreson of Phillips Medisize discuss the company’s expanded capabilities as a result of its recent acquisition of Vectura. Learn more.
OIC
PMPS: Elevate Your Molecule
Phillips Medisize’s 2025 acquisition of Vectura expanded its offerings to include inhaled drug development for small molecules, biologics and complex combinations for both novel and generic products. Learn more.